. Author manuscript; available in PMC: 2012 Oct 1.

Published in final edited form as: Urology. 2011 Aug 5;78(4):970.e15–970.e20. doi: 10.1016/j.urology.2011.05.035

Table 2. Frequencies of other malignancies in 1121 prostate cancer (CaP) probands and their first-degree relatives.

Malignancy	No. (%) of CaP probands with malignancy	No. (%) of CaP probands with at least 1 first-degree relative with malignancy	Lifetime risk (%) of being diagnosed with cancer – caucasian males²⁸	Lifetime risk (%) of being diagnosed with cancer – caucasian females²⁸
Non-melanoma skin cancer	153 (13.6%)	46 (4.1%)	20²⁹	20²⁹
Leukemia	82 (7.3%)	38 (3.4%)	1.62	1.15
Melanoma	44 (3.9%)	47 (4.2%)	2.73	1.82
Non-Hodgkin’s lymphoma	8 (0.7%)	35 (3.1%)	2.43	2.02
Colorectal cancer	7 (0.6%)	113 (10.1%)	5.30	4.90
Multiple myeloma	3 (0.3%)	4 (0.4%)	0.70	0.51
Breast	^*	167 (14.9%)	0.13	12.57

Breast cancer in CaP patients was not examined.